AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
AAC Accepts, published online ahead of print on 10 March 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.01449-07v1
52/5/1670    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, M. J.
Right arrow Articles by Lombès, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, M. J.
Right arrow Articles by Lombès, A.

 Previous Article  |  Next Article 

Antimicrob. Agents Chemother. doi:10.1128/AAC.01449-07
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Mitochondrial DNA content: an inaccurate biomarker of mitochondrial alteration in HIV-related lipodystrophy

Min Ji Kim, Claude Jardel, Cyrille Barthélémy, Véronique Jan, Jean Philippe Bastard, Sandrine Fillaut-Chapin, Sydney Houry, Jacqueline Capeau, and Anne Lombès*

Inserm, U582, Paris, F-75013, France; Université Pierre et Marie Curie (UPMC-Paris 6), Paris, France; Inserm, U680, Paris, F-75012, France; AP-HP, Hôpital Pitié-Salpêtrière, Service de Biochimie, Paris, F-75651 France; AP-HP, Service de Biochimie, and Service de Chirurgie, Hôpital Tenon, Paris, F-75020 France

* To whom correspondence should be addressed. Email: a.lombes{at}institut-myologie.org.


   Abstract

Lipoatrophy is a prevalent side effect of antiretroviral treatment of HIV infection. Its mechanisms are still disputed but include mitochondrial toxicity, in particular mitochondrial DNA (mtDNA) depletion induced by nucleoside reverse transcriptase inhibitors. To obtain an integrated evaluation of the mitochondrial alteration in lipoatrophy, we investigated its DNA, RNA and protein levels in 15 samples of abdominal subcutaneous adipose tissue from HIV-infected patients with peripheral lipoatrophy and compared them with 15 samples from age- and BMI-matched controls. DNA and RNA analyses used PCR-based techniques while proteins were quantified with ELISA and activity with spectrophotometric assays.

Depletion of mtDNA and mtDNA-encoded MT-CO2 mRNA was present but normal levels of mtDNA-dependent activity (cytochrome c oxidase) and protein (MT-CO2p) showed that it was compensated for. Increase of nuclear DNA-dependent mitochondrial activities (citrate synthase and malate dehydrogenase) and protein (COX4I1p) as well as transcriptional up-regulation of nuclear DNA-encoded mitochondrial genes (COX4I1 and UCP2) demonstrated increased mitochondrial biogenesis. However expression of the known transcription factors of mitochondrial biogenesis (TFAM, NRF1, GABPA, PPARGC1A, PPARGC1B, and PPRC1) was normal or decreased. Increased amount of activated caspase 3 and of DDIT3 mRNA showed the induction of apoptosis and oxidative stress respectively. The mtDNA content did not correlate with any other mitochondrial parameter

In conclusion, mtDNA content does not appear to be an accurate biomarker of mitochondrial alteration in lipoatrophic adipose tissue. Preservation of mtDNA-dependent mitochondrial functions occurred despite severe mtDNA depletion. The presence of significant oxidative stress and apoptosis did not correlate with mtDNA content.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.